30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Absci Corp (ABSI)

Track

Over the last 90 days, Absci Corp has seen net insider buying totaling $429,748, with two insiders making purchases. Notably, Chief Innovation Officer Andreas Busch bought $229,000 worth of stock. The company's stock has experienced significant positive price movement in the past 90 days.
Stock chart
Ticker: ABSI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Pangalos Menelas N
1 purchase — total 200,748 USD
Buy 13 May 2026
Value US$3,205,482.87 | Price 407.46 | Shares 32,307
Buy 12 Mar 2026
Value US$4,984,887.21 | Price 46.60 | Shares 99,992
Buy 27 Feb 2026
Value US$205,760.30 | Price 2.74 | Shares 75,095
Sale 2 Feb 2026
Value US$52,313.04 | Price 2.99 | Shares 17,496
Sale 2 Feb 2026
Value US$80,015.39 | Price 2.99 | Shares 26,761
Buy 5 Dec 2025
Value US$148,800.00 | Price 3.72 | Shares 40,000
Buy 22 Sep 2025
Value US$254,788.10 | Price 2.66 | Shares 95,785
Buy 22 Sep 2025
Value US$27,000.00 | Price 2.70 | Shares 10,000
Buy 28 Jul 2025
Value US$152,000.00 | Price 3.04 | Shares 50,000
Sale 13 Jun 2024
Value US$98,891.86 | Price 4.98 | Shares 19,859
Proposed sale 13 Jun 2024
Value US$98,891.86 | Price 4.98 | Shares 19,859
Sale 22 May 2024
Value US$13,640,000.00 | Price 4.40 | Shares 3,100,000
Buy 1 Mar 2024
Value US$999,999.00 | Price 4.50 | Shares 222,222
Buy 9 Feb 2022
Value US$33,830.00 | Price 7.96 | Shares 4,250
Buy 20 Jan 2022
Value US$15,000.00 | Price 7.50 | Shares 2,000
Buy 19 Jan 2022
Value US$49,512.60 | Price 6.92 | Shares 7,155
Buy 26 Jul 2021
Value US$160,000.00 | Price 16.00 | Shares 10,000
Buy 26 Jul 2021
Value US$25,000,000.00 | Price 16.00 | Shares 1,562,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-13 B Purchase
3.6
Pangalos Menelas N
Non-Executive Director
32,307 -23.3%
407.46
US$3,205,483 		32,307 -23.3% 407.46 US$3,205,483
2026-03-16 2026-03-12 B Purchase
4.0
Busch Andreas

Chief Innovation Officer

Officer
99,992 +47.1%
46.60
US$4,984,887 		99,992 +47.1% 46.60 US$4,984,887
2026-03-03 2026-02-27 B Purchase
3.6
Pangalos Menelas N
Non-Executive Director
65,735 +5.9%
88.34
US$1,060,369 		65,735 +5.9% 88.34 US$1,060,369
2026-02-04 2026-02-02 S Sale
2.6
Jonasson Zachariah

CFO / CBO

Officer
17,496 -4.4%
2.99
US$52,313 		17,496 -4.4% 2.99 US$52,313
2026-02-04 2026-02-02 S Sale
1.5
McClain Sean

Chief Executive Officer

Executive Director
26,761 -0.3%
2.99
US$80,015 		26,761 -0.3% 2.99 US$80,015
2025-12-09 2025-12-05 B Purchase
1.3
VAN HOUTEN FRANS
Non-Executive Director
40,000 +171.5%
3.72
US$148,800 		40,000 +171.5% 3.72 US$148,800
2025-09-24 2025-09-22 B Purchase
3.6
Pangalos Menelas N
Non-Executive Director
95,785 +527.0%
2.66
US$254,788 		95,785 +527.0% 2.66 US$254,788
2025-09-24 2025-09-22 B Purchase
3.3
Bedrick Todd

SVP, CAO

Officer
10,000 +5.9%
2.70
US$27,000 		10,000 +5.9% 2.70 US$27,000
2025-07-29 2025-07-28 B Purchase
4.0
Busch Andreas

Chief Innovation Officer

Officer
50,000 +18.0%
3.04
US$152,000 		50,000 +18.0% 3.04 US$152,000
2024-06-14 2024-06-13 S Sale
2.6
Jonasson Zachariah

CFO / CBO

Officer
19,859 -4.9%
4.98
US$98,892 		19,859 -4.9% 4.98 US$98,892
2024-06-13 2024-06-13 PrS Proposed sale
2.6
ZACHARIAH JONASSON

Officer

Officer
19,859
4.98
US$98,892 		19,859 4.98 US$98,892
2024-05-28 2024-05-22 S Sale
2.9
Phoenix Venture Partners II LP
Large shareholder
3,100,000 -21.6%
4.40
US$13,640,000 		3,100,000 -21.6% 4.40 US$13,640,000
2024-03-05 2024-03-01 B Purchase
3.2
Redmile Group, LLC
Non-Executive Director
222,222 +2.8%
4.50
US$999,999 		222,222 +2.8% 4.50 US$999,999
2022-02-10 2022-02-09 B Purchase
1.4
Korman Sarah

General Counsel

Officer
4,250 +42.5%
7.96
US$33,830 		4,250 +42.5% 7.96 US$33,830
2022-01-24 2022-01-20 B Purchase
3.3
Bedrick Todd

VP, CCPAO

Officer
2,000 +200.0%
7.50
US$15,000 		2,000 +200.0% 7.50 US$15,000
2022-01-19 2022-01-19 B Purchase
1.5
McClain Sean

President and Chief Executive

Executive Director
7,155 +0.1%
6.92
US$49,513 		7,155 +0.1% 6.92 US$49,513
2021-07-28 2021-07-26 B Purchase
1.4
Korman Sarah

General Counsel

Officer
10,000 +inf%
16.00
US$160,000 		10,000 +inf% 16.00 US$160,000
2021-07-28 2021-07-26 B Purchase
3.3
Casdin Partners Master Fund, L.P.
Non-Executive Director
1,562,500 +30.1%
16.00
US$25,000,000 		1,562,500 +30.1% 16.00 US$25,000,000
Explore more

More insider trading research around Absci Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America